Debridat 100mg Pfizer drugs treat pain symptoms, gut peristalsis and intestinal discomfort (30 tablets)

Dosage form Box of 2 blisters x 15 tablets
Specifications Trimebutine
Ingredient Farmea

Ingredient

Composition information	Content
Trimebutine	100mg

Uses

Indications

Debridat drugs are indicated in the following cases:

Treatment of pain is associated with dysfunction of the gastrointestinal tract and bile ducts.

Treatment of pain, intestinal peristaltic disorders, intestinal discomfort associated with intestinal dysfunction.

Pharmacy

Debridat changes the movement capacity of the digestive tract, the agent on the peripheral Enkephalin system.

Trimebutin stimulates the movement of the intestine (causing the wave of phase III to spread thanks to the movement complex) and inhibit the motor ability when there is a previous stimulation.

trimebutine: anti -spasms.

pharmacokinetics

Trimebutin's peak concentration after using oral tablets achieved after 1-2 hours.

Trimebutin is deducted quickly after oral tablets, mainly through urine, on average about 70% for 24 hours.

Before taking Debridat 100mg Pfizer drugs treat pain symptoms, gut peristalsis and intestinal discomfort (30 tablets)

How to use

Debridat drugs are used by oral.

Dosage

Debridat medicine is only for adults.

The usual dose is 1 tablet x 3 times daily. In exceptions, the dose may increase to 6 tablets/day.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when more than 1 dose? In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not drink twice as prescribed.

Side Effects

The unwanted effects of the drug in the table below have been reported in patients using trimebutin (see Appendix A - The frequency of unwanted effects of the drug from clinical trials).

Classification by system/agency according to Meddra#

Frequency

Unwanted effects of the drug

immune system disorders

Unknown

Hypersensitivity*t

Not common

Fainting money/fainting **

Not common

Rashes

Unknown

Serious skin reactions include acute bodies of acne pustules*, diverse roses*, skin poisoning rash*, flaking dermatitis*and contact dermatitis*; Dermatitis*, Hong Ban*, itching*and urticaria*

Very rare

# Meddra version 15.

* ADR is determined after the drug circulates.

** Observed mainly when using the injection form.

The vibrant reaction to the drug is reported after the drug is mainly related to the skin (for example: contact dermatitis, dermatitis, itching, urticaria).

classification by system/agency

Unwanted effects of the drug

(in common terms)

Frequency (%)

immune system disorders

Hypersensitivity reaction

Fainting money/fainting **

3/1257 (0.24)

Rashes

5/1939 (0.26)

Serious skin reactions include acute all -body pustules*, diverse roses*, skin poisoning rash*, peeling dermatitis*and contact dermatitis*; Dermatitis*, Hong Ban*, itching*and urticaria*

** Observed mainly when using the injection form.

The hypersensitivity reaction to the drug is reported after the drug is mainly related to the skin (for example: contact dermatitis, dermatitis, itching, urticaria).

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Debridate drugs are contraindicated to use Debridat for patients sensitive to trimebutin maleat or any other ingredient of the drug.

Precautions when used

The absolutely contraindications and caution has been determined for this active ingredient. No data has been recorded at this time.

The ability to drive and operate machinery

There is no systematic evaluation of the influence of trimebutin on the ability to drive and operate machinery.

Pregnancy or nursing mothers

Pregnancy

Animal research has not detected a teratogenic effect. There is no complete and well -controlled study of trimebutin in pregnant women. There is no evidence of the likelihood of monitoring or unwanted effects on fetal development when used in mice and pregnant rabbits. Trimebutin should only be used during pregnancy when the potential benefits for patients are much higher than the risk that may occur to patients and fetus.

Breastfeeding period

Safety when using Debridat during breastfeeding has not been established.

Drug interaction

There has been no report on drug interaction.

Storage

Store below 25 ° C.

Expiry date: 36 months from the date of production.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.